What Happened?
South San Francisco, CA-based Antiva-Biosciences Appointed Gail Maderis as President and Chief Executive Officer
Date of management change: July 15, 2015
South San Francisco, CA-based Antiva-Biosciences Appointed Gail Maderis as President and Chief Executive Officer
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antiva`s chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.
Gail Maderis is President and Chief Executive Officer at Antiva Biosciences. Previously, Gail held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Winter Rick, Morris Bernard, Singh Rajiv, Doorley Christopher, Nocket JM, Haban Paulette, Chaher Gabriel, Hindawi Orion, Pannullo Michael, Riesenburger Nathan, Carkeek Susan
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.